Both in Pharmaceuticals
Theriva Biologics vs Actuate Therapeutics
Over the past year TOVX returned −43.4% and ACTU returned −94.9%; their daily moves had a correlation of 0.16.
TOVX −43.4% ACTU −94.9%Growth of $1, one year, split-adjusted
| Metric | TOVX | ACTU |
|---|---|---|
| Price | $0.1840 | $0.3420 |
| Market cap | $8.4M | $8.2M |
| Today | +7.92% | +2.06% |
| 1 month | −18.3% | −58.2% |
| 6 months | −51.5% | −88.4% |
| Year to date | −12.5% | −94.4% |
| 1 year | −43.2% | −94.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 28.1× | — |
| Net cash | $9.7M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 161.3% |
| Short % of float | 4.0% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).